Company Overview of Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc., a biotechnology company, develops adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer in the fields of human and animal health. It offers JVRS-100, a cationic lipid-DNA complex and adjuvant that improves the effectiveness of existing vaccines, as well as helps in developing vaccines against infectious diseases. The company’s product is also used for the treatment of viral, bacterial, and cancer diseases. Juvaris BioTherapeutics, Inc. has a strategic alliance with Bayer HealthCare AG. The company was incorporated in 2001 and is headquartered in Pleasanton, California.
6200 Stoneridge Mall Road
Pleasanton, CA 94588
Founded in 2001
Key Executives for Juvaris BioTherapeutics, Inc.
Similar Private Companies By Industry
|Neurolixis, Inc.||United States|
|Creatics LLC||United States|
|Envisia Therapeutics Inc.||United States|
|Transcription Factor Therapeutics, Inc.||United States|
|Otologic Pharmaceutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Juvaris BioTherapeutics, Inc., please visit www.juvaris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.